Peptide Groove LLP OC386261 false 2022-07-01 2023-06-30 2023-06-30 The principal activity of the company is scientific development. Digita Accounts Production Advanced 6.30.9574.0 OC386261 2022-07-01 2023-06-30 OC386261 2023-06-30 OC386261 bus:Micro-entities 2022-07-01 2023-06-30 OC386261 bus:AuditExemptWithAccountantsReport 2022-07-01 2023-06-30 OC386261 bus:FilletedAccounts 2022-07-01 2023-06-30 OC386261 bus:RegisteredOffice 2022-07-01 2023-06-30 OC386261 bus:PartnerLLP3 2022-07-01 2023-06-30 OC386261 bus:LimitedLiabilityPartnershipLLP 2022-07-01 2023-06-30 OC386261 countries:AllCountries 2022-07-01 2023-06-30 OC386261 2021-07-01 2022-06-30 OC386261 2022-06-30 iso4217:GBP xbrli:pure

Registration number: OC386261

Peptide Groove LLP

Annual Report and Unaudited Financial Statements

for the Year Ended 30 June 2023

 

Peptide Groove LLP

Contents

Financial Statements

1 to 2

Balance Sheet

1

Notes to the Financial Statements

2

 

Peptide Groove LLP

(Registration number: OC386261)
Balance Sheet as at 30 June 2023

2023
 £

2022
 £

Current assets

247,620

354,066

Prepayments and accrued income

27,842

24,456

Total assets less current liabilities

275,462

378,522

Accruals and deferred income

(2,077)

(1,140)

Net assets attributable to members

273,385

377,382

Represented by:

Loans and other debts due to members

273,285

377,282

Members' other interests

100

100

 

273,385

377,382

Total members' interests

Loans and other debts due to members

273,285

377,282

Equity

100

100

 

273,385

377,382

 

Peptide Groove LLP

(Registration number: OC386261)
Balance Sheet as at 30 June 2023 (continued)

1

General information

The place of registration of the limited liability partnership is England and Wales.

The address of the registered office is:
Leat Cottage
Church Lane
Charlton On Otmoor
Kidlington
OX5 2UA

The limited liability partnership is incorporated in England and Wales under the Limited Liability Partnership Act 2000.

Basis of preparation

These financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 105 - 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The average number of persons employed by the limited liability partnership (including members) during the year was 4 (2022 - 4).

These financial statements have been prepared in accordance with the provisions applicable to LLPs subject to the micro-entities regime and FRS 105 ‘The Financial Reporting Standard Applicable to the Micro-entities Regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime, as applied to small limited liability partnerships.

For the year ending 30 June 2023 the limited liability partnership was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied to limited liability partnerships, relating to small entities.

The members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006, as applied to limited liability partnerships by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 with respect to accounting records and the preparation of accounts.

The financial statements of Peptide Groove LLP (registered number OC386261) were approved by the Board and authorised for issue on 31 January 2024. They were signed on behalf of the limited liability partnership by:


G McVean
Designated member